A re­port in­to the death of 60-year-old Ijaz "EG" Han­iff has been sub­mit­ted to the Chief Med­ical Of­fi­cer Dr Roshan Paras­ram and sent to the South­west Re­gion­al Health Au­thor­i­ty (SWRHA).

The SWRHA is ex­pect­ed to meet with Han­iff's fam­i­ly at a lat­er date to dis­cuss the find­ings.

Han­iff, a car­diac pa­tient, was in­oc­u­lat­ed with the As­traZeneca vac­cine and with­in eight days he de­vel­oped blood clots, be­came paral­ysed and sub­se­quent­ly died.

Paras­ram con­firmed the re­port on Sat­ur­day at the Min­istry of Health's COVID-19 up­date.

"The South­west Re­gion­al Health Au­thor­i­ty would have sub­mit­ted to my of­fice a clin­ic re­port re­lat­ed to that par­tic­u­lar event. I have al­so sent it to my haema­tol­o­gist who works at the Min­istry of Health," Paras­ram said.

"The mat­ter is be­fore the SWRHA, who has con­tact­ed the rel­a­tives of that par­tic­u­lar in­di­vid­ual and they would be hav­ing a full dis­clo­sure clin­i­cal meet­ing with all the clin­i­cian in­volved in the near fu­ture."

He said that once that was com­plet­ed, the SWRHA may is­sue a state­ment to up­date the pub­lic.

Paras­ram said that most peo­ple who have had the in­jec­tion de­scribed pain at the in­jec­tion site and mild symp­toms that have all been re­solved.

Paras­ram said that in­stances of blood clots af­ter the in­jec­tion are "ex­treme­ly rare" even though it has trig­gered a sus­pen­sion of the As­traZeneca vac­cine by some 18 coun­tries through­out the world.

"It is an ex­treme­ly rare com­pli­ca­tion of the vac­cine. There is noth­ing you can take be­fore you have the vac­cine to off­set the sort of re­ac­tion that may hap­pen, noth­ing that is rec­om­mend­ed by WHO at this time," he said.

Paras­ram said if any­one had an al­ler­gic re­ac­tion to the first shot then they should have the sec­ond fol­low-up in­jec­tion.

Mean­while, To­ba­go has rolled in­to phase 2 of its vac­ci­na­tion process where peo­ple un­der 60 are now be­ing in­oc­u­lat­ed. Trinidad is still in the first phase.